Reference:
1. Swerdlow SH CE, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. .WHO Classification of Tumours of Haematopoietic and Lymphoid
Tissues, Revised Fourth Edition. Vol 2. Lyon, France: IARC/WHO Press;
2017.
2. Campo E, Jaffe ES, Cook JR, et al. The International Consensus
Classification of Mature Lymphoid Neoplasms: a report from the Clinical
Advisory Committee. Blood. 2022;140(11):1229-1253.
3. Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the
World Health Organization Classification of Haematolymphoid Tumours:
Lymphoid Neoplasms. Leukemia. 2022;36(7):1720-1748.
4. Rubinstein J, Toner K, Gross T, Wistinghausen B. Diagnosis and
management of post-transplant lymphoproliferative disease following
solid organ transplantation in children, adolescents, and young adults.Best Pract Res Clin Haematol. 2023;36(1):101446.
5. Cheng J, Wistinghausen B. Clinicopathologic Spectrum of Pediatric
Posttransplant Lymphoproliferative Diseases Following Solid Organ
Transplant. Arch Pathol Lab Med. 2023.
6. Wistinghausen B, Gross TG, Bollard C. Post-transplant
lymphoproliferative disease in pediatric solid organ transplant
recipients. Pediatr Hematol Oncol. 2013;30(6):520-531.
7. Ramadas P, Williams M, Duggan DB. Plasmablastic Lymphoma or
Plasmablastic Myeloma: A Case of Post-Transplant Lymphoproliferative
Disorder. Case Rep Hematol. 2021;2021:4354941.
8. Lambe JS, Oble DA, Nandula SV, et al. KHSV(-) EBV(-) post-transplant
effusion lymphoma with plasmablastic features: variant of primary
effusion lymphoma? Hematol Oncol. 2009;27(4):203-210.
9. Zimmermann H, Oschlies I, Fink S, et al. Plasmablastic posttransplant
lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus
association linked with poor outcome in the prospective German
Posttransplant Lymphoproliferative Disorder Registry.Transplantation. 2012;93(5):543-550.
10. Morscio J, Dierickx D, Nijs J, et al. Clinicopathologic comparison
of plasmablastic lymphoma in HIV-positive, immunocompetent, and
posttransplant patients: single-center series of 25 cases and
meta-analysis of 277 reported cases. Am J Surg Pathol.2014;38(7):875-886.
11. Leeman-Neill RJ, Soderquist CR, Montanari F, et al. Phenogenomic
heterogeneity of post-transplant plasmablastic lymphomas.Haematologica. 2022;107(1):201-210.
12. Choudhuri J, Pan Z, Yuan J, et al. CD138- Plasmablastic Lymphoma: A
Multi-institutional Study and Review of the Literature. Arch
Pathol Lab Med. 2023;147(6):643-654.
13. Migliavacca M, Assanelli A, Ponzoni M, et al. First Occurrence of
Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined
Immunodeficiency Disease Patient and Review of the Literature.Front Immunol. 2018;9:113.
14. Pan Z, Chen M, Zhang Q, et al. CD3-positive plasmablastic B-cell
neoplasms: a diagnostic pitfall. Mod Pathol. 2018;31(5):718-731.
15. Chen BJ, Yuan CT, Yang CF, et al. Plasmablastic myeloma in Taiwan
frequently presents with extramedullary and extranodal mass mimicking
plasmablastic lymphoma. Virchows Arch. 2022;481(2):283-293.
16. Zhou T, Cheng J, Karrs J, et al. Clinicopathologic and Molecular
Characterization of Epstein-Barr Virus-positive Plasmacytoma. Am J
Surg Pathol. 2022;46(10):1364-1379.
17. Chang CC, Zhou X, Taylor JJ, et al. Genomic profiling of
plasmablastic lymphoma using array comparative genomic hybridization
(aCGH): revealing significant overlapping genomic lesions with diffuse
large B-cell lymphoma. J Hematol Oncol. 2009;2:47.
18. Laurent C, Fabiani B, Do C, et al. Immune-checkpoint expression in
Epstein-Barr virus positive and negative plasmablastic lymphoma: a
clinical and pathological study in 82 patients. Haematologica.2016;101(8):976-984.
19. Montes-Moreno S, Martinez-Magunacelaya N, Zecchini-Barrese T, et al.
Plasmablastic lymphoma phenotype is determined by genetic alterations in
MYC and PRDM1. Mod Pathol. 2017;30(1):85-94.
20. Fu Z, Wang H, Lauwers GY, et al. Primary plasmablastic lymphoma of
the gastrointestinal tract: A series of 13 HIV-negative cases and a
review of literature. Ann Diagn Pathol. 2023;67:152204.
21. Nessim Kostandy E, Wan D, Imseis E. Rare Case of Pediatric
Post-transplant Lymphoproliferative Disorder Presenting With Pleural
Masses Complicated by Pleural Effusions. ACG Case Rep J.2023;10(9):e01158.
22. Gisriel SD, Yuan J, Braunberger RC, et al. Human herpesvirus
8-negative effusion-based large B-cell lymphoma: a distinct entity with
unique clinicopathologic characteristics. Mod Pathol.2022;35(10):1411-1422.
23. Teruya-Feldstein J, Chiao E, Filippa DA, et al. CD20-negative
large-cell lymphoma with plasmablastic features: a clinically
heterogenous spectrum in both HIV-positive and -negative patients.Ann Oncol. 2004;15(11):1673-1679.
24. Di Napoli A, Soma L, Quintanilla-Martinez L, et al. Cavity-based
lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH
lymphoma workshop. Virchows Arch. 2023.
25. Liu Z, Filip I, Gomez K, et al. Genomic characterization of
HIV-associated plasmablastic lymphoma identifies pervasive mutations in
the JAK-STAT pathway. Blood Cancer Discov. 2020;1(1):112-125.
26. Ramis-Zaldivar JE, Gonzalez-Farre B, Nicolae A, et al. MAPK and
JAK-STAT pathways dysregulation in plasmablastic lymphoma.Haematologica. 2021;106(10):2682-2693.
27. Witte HM, Kunstner A, Hertel N, et al. Integrative genomic and
transcriptomic analysis in plasmablastic lymphoma identifies disruption
of key regulatory pathways. Blood Adv. 2022;6(2):637-651.
28. Vergote VKJ, Deroose CM, Fieuws S, et al. Characteristics and
Outcome of Post-Transplant Lymphoproliferative Disorders After Solid
Organ Transplantation: A Single Center Experience of 196 Patients Over
30 Years. Transpl Int. 2022;35:10707.
29. Sultana S, Salihi SA, Tandon N, et al. Post-transplant
Lymphoproliferative Disorder Presented in a Form of Primary Effusion
Lymphoma with t (8; 14). Ann Clin Lab Sci. 2017;47(3):344-348.
30. Ohori NP, Whisnant RE, Nalesnik MA, Swerdlow SH. Primary pleural
effusion posttransplant lymphoproliferative disorder: Distinction from
secondary involvement and effusion lymphoma. Diagn Cytopathol.2001;25(1):50-53.
31. Hoffmann H, Schlette E, Actor J, Medeiros LJ. Pleural
posttransplantation lymphoproliferative disorder following liver
transplantation. Arch Pathol Lab Med. 2001;125(3):419-423.